Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

 

3. FDA approves Siemens 3D breast tomo device

Siemens Healthcare said the FDA approved a new breast tomosynthesis option for its Mammomat Inspiration digital mammography device.

Malvern, Pa.-based Siemens Healthcare said its BT algorithm compiles 2-dimensional breast images into a 3-dimensional construct “to enable detection of tumors that are hidden by overlapping breast tissue.” Read more

2. Appeals court declines Medtronic’s review bid in NuVasive spat

A federal appeals court this week declined Medtronic’s motion to re-hear its decision overturning the lost profits it won in a long-running patent infringement war with spine implant rival NuVasive Inc.

The U.S. Court of Appeals for the Federal Circuit decided in March that a lower court erred in 2011 when it awarded Medtronic $101.2 million in the case, ordering a new trial to determine the correct amount of damages. Read more

1. Supremes deny BD bid for appeal in Retractable Technologies case

Becton Dickinson & Co. this week lost its bid for a U.S. Supreme Court review of its patent infringement loss to safety syringe maker Retractable Technologies.

The Supremes denied BD’s petition for a writ of certiorari April 20, ending 1 chapter in the companies’ long-running battle over the patents covering RTI’s VanishPoint syringes. Read more